Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

AADvac 1

Next Previous
Drug Profile

AADvac 1

Alternative Names: AADvac-1; Alzheimer's disease vaccine - Axon Neuroscience; Axon peptide 108 conjugated to KLH; Axon peptide 108 coupled to KLH

Latest Information Update: 28 Aug 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Axon Neuroscience
  • Class Alzheimer vaccines; Conjugate vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Alzheimer's disease; Progressive supranuclear palsy
  • Phase I Aphasia

Most Recent Events

  • 29 Jul 2026 Phase-II clinical trials in Progressive supranuclear palsy in USA (unspecified route) (NCT07173803)
  • 29 Jul 2026 Axon Neuroscience in collaboration with University of California initiates a phase II trial for Progressive supranuclear palsy in USA (SC) (NCT07217665)
  • 12 Jan 2026 phase-I development in Aphasia is ongoing in Germany (SC, Injection) (Axon Neuroscience pipeline; January 2026)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top